Embed Size (px)
Citation preview
Madrid , 5 Junio 2016
H2020 - JTI-BBI-2016 CÓMO PREPARAR UNA PROPUESTA EXITOSA
Marta Conde Vidal National Contact Point SC2 Bioeconomy & LEIT Biotechnolgy José Manuel González Spanish Delegate SC2 Bioeconomy CDTI.- Ministry of Economy and Competitiveness International Programmes Directorate European Programmes Division +34 91 581 55 62.- [email protected]; [email protected]
2
Índice de contenidos
• Portal del participante.
• El topic
• El evaluador. Parte I. El proceso de evaluación.
• La elaboración de la propuesta. La guía del participante.
• El evaluador. Parte II. Lo que va buscando!!
• Documentos de interés.
3
El Portal del Participante & Annual Work Plan 2016
http://www.bbi-
europe.eu/sites/default/files/documents/bbi-
ju-awp-2016-final_en.pdf
http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/index.html
4
Portal del participante http://ec.europa.eu/research/participants/portal/desktop/en/home.html
5
The BBI JU follows the rules of the European Union’s Horizon 2020 framework programme (H2020).
Derogation of Article 10 of Regulation EU 1290/2013.
Guide for Applicants:
1.- Call information: What is JTI –BBI, how it works.
2.- About the funding schemes (examples)
Annexes:
• Annex 1: Timetable & specific information for the 2016 call.
• Annex 2: Evaluation Criteria & Procedures to be applied.
• Annex 3: Instructions for Completing “Part A” of the Proposal.
• Annex 4: Instructions for Drafting “Part B” of the proposal.
• Annex 5: Part B Template for IA, RIA and CSA.
¿Cómo funciona la convocatoria JTI-BBI-2016?
6
La idea debe ajustarse al topic del WP, encaje perfecto
Tener en cuenta todas las indicaciones (TRLS, presupuesto, referencias a otros topics y convocatorias) y dar respuesta
a todos los impactos señalados (KPI)
Cada frase cuenta, es el resultado de la negociación entre la industria y la CE.
Competición entre líneas presupuestarias (5 líneas en 2016 )
CSA, RIA, DEMO, F1 Y F2
Título
Alcance
Instrumento
Impacto esperado
Reto específico
El proyecto ha de cubrir todo lo descrito en el topic (reto, alcance, impactos, con el
instrumento indicado)
BBI 2016.R7 - Biopolymers with advanced functionalities for high
performance applications
Specific challenge: With an expected significant growth in the next 4 years,
biopolymers represent one of the leading sectors for bio-based products. The
main driver behind this trend has up to now been the need to substitute
conventional fossil-based materials with more sustainable bio-based ones, in
particular in large volume consumer products such as packaging.
……
Scope: develop and validate biopolymers with advanced functionalities for
demanding sectors such as (but not limited to):
- the biomedical sector, requiring biopolymers and derived materials with
bio-compatibility and/or surface functionalisation (such as for antibacterial
purposes);
- the construction, automotive and aerospace sectors, in need of biopolymers
to produce lightweight plastics and composites with excellent structural
properties.
Proposals should …….
The projects should cover any Technology Readiness Level (TRL) from 3
to 5. In the case of a pilot scale project (TRL 5), proposals should present a
credible cost estimate for the proposed processes with a preliminary
assessment of their competitiveness when scaled up.
Proposals should also include an environmental and socio-economic
assessment, for example with an LCA. In particular, when targeting TRL 5,
proposals should include an LCA in order to evaluate the environmental and
socio-economic performance of the developed processes.
It is considered that proposals with a total eligible budget in the range of
EUR 2-5 million would allow this specific challenge to be addressed
appropriately. Nonetheless, this does not preclude submission and selection
of proposals with another budget. 32
Expected impacts:
Validated, enhanced properties with substantial advancements as compared
to best available products:
Completely new functionalities with clear added-value in new applications.
Contribution to the BBI JU Key Performance Indicators (KPI), specifically:
Set the basis for the realisation of new bio-based materials (KPI 5) and new
demonstrated consumer products based on bio-based chemicals and materials
(KPI 6).
Type of action: Research and Innovation Action
El topic en el AWP 2016
7
Key Performance Indicators (KPI) (page28 SIRA)
KPI BBI KEY OBJECTIVES
KPI1 New cross-sectorial interconnection in bio-based economy clusters
KPI4 New building block based on biomass of European origin validated at demonstration scale
KPI2 New bio-based value chain KPI5 New bio-based material
KPI3 New cooperation project KPI6 New demonstrated consumer products based on bio-based chemicals and materials
8
El evaluador!!
http://ec.europa.eu/research/participants/portal/desktop/en/exp
erts/index.html
“Si no puedes con tu enemigo, únete a él”
9
El proceso de evaluación y puntuación
• Peer-review by independent experts from Horizon 2020 database • Each proposal assessed by at least 3 independent experts • Evaluation in 3 phases: individual evaluation, consensus group, panel review. • For flagship actions (panel review – may organize hearings with BBI-JU)
Award criteria
Excellence Impact Implementation Overall theshold
RIA-CSA 3/5 4/5
3/5
11/15
IA 3/5
4/5*
3/5
11/15
* Innovation actions, the criterion impact will be given a weighting of 1,5
10
EVALUATION CRITERIA
EXCELLENCE (3/5)
Clarity and pertinence of the objectives; Soundness of the concept and credibility of the proposed methodology; Interdisciplinary considerations and stakeholder Knowledge; Extent that proposed work is ambitious, has innovation potential, and is beyond the state of the art (RIA &IA); Coverage of the value chain (raw materials, equipment and technology suppliers and end-users) (IA); Quality of the proposed coordination and/or support measures; (CSA)
IMPACT (4/5)
The expected impacts listed in the BBI-JU annual Work Plan under the relevant topic; Any substantial impacts to enhance innovation capacity, market oportunities, competitiveness, climate change, benefits to society (RIA, IA) Quality of the measures to exploit, disseminate & communicate project results (IPR management) Extent to which consortium own contribution, including additional investments (IA), will help maximising the impact of the action (RIA)
Q&E of IMPLEMENTATION (3/5)
- Quality & effectiveness of the work plan, allocation of tasks and resources; - Complementarity of the participants within the consortium; - Appropriate management structures and procedures, including risk and innovation management ; - Soundness of the business case and business plan (IA); - Readiness of the technology for the implementation of the pilot phase, demonstration or flagship (IA)
11
Elaboración y presentación de
la propuesta
12
Formularios: Ejemplo Research & Innovation /Innovation Action
A B
Datos administrativos y financieros Formato PDF
Contenido técnico de la propuesta Formato Word → PDF
13
Formulario B:
Full proposals (single stage)
• Cover page + Sections 1, 2 and 3 together ≤ 70 pages (CSA ≤ 50 pages)
(All tables included within this limit)
• Min. font size = 11 points.
• Page size = A4
• All margins (top, bottom, left, right) ≥ 15 mm (not including any footers or headers).
14
Cover page
Formulario B: Ejemplo Research & Innovation/Innovation Action
15
Formulario B: BBI JU vs. H2020 Ejemplo Research & Innovation/Innovation Action
1. Excellence 1.1 Objectives. Clear, measurable, realistic, … Industrial/economic /social problem to overcome. Business opportunity. How your solution solves the stated problem.
1.2 Relation to the BBI JU annual Work Plan. 1.3 Concept and methodology 1.4 Ambition Beyond the state-of-the-art Innovation potential How the proposal covers the whole value chain
16
Formulario B: BBI JU vs. H2020 Ejemplo Research & Innovation/Innovation Action
2. Impact 2.1 Expected impacts Impacts mentioned in BBI topic. Other impacts on innovation capacity/market oportunities, competitiveness, climate change, benefits to society Barriers/obstacles
Describe and provide estimate additional investment 2.2 Measures to maximise impact
a)Dissemination and exploitation of results Provide a draft for disemination & exploitation plan. For IA describe the path to deliver innovations to de market. Follow up once finished, additional investments, regulation. IPR - Open access (green/gold).
b)Communication activities
17
3. Implementation 3.1 Work plan — Work packages, deliverables and milestones
Table 3.1a: Work package description Table 3.1b: List of work packages Table 3.1c: List of Deliverables For RIA, how developments will contribute to the creation of new biobased value chains. For IA, Business plan justified by a throrough business case & description of existing facilities & additional investments.
Formulario B: BBI JU vs. H2020 Ejemplo Research & Innovation/Innovation Action
Business case Business plan
Business need Sales Forecast & Personnel Plan
Benefits and costs of the options; preferred option;
Profit & Loss Statement
Risk identification and mitigation strategy Cash Flow Statement
Implementation strategy. Balance Sheet
A description of the business
18
3. Implementation
3.2 Management structure and procedures Table 3.2a: List of milestones Table 3.2b: Critical risks for implementation
3.3 Consortium as a whole 3.4 Resources to be committed
Table 3.4a: Summary of staff effort (table 3.4a) Table 3.4b: ‘Other direct cost’ items (travel, equipment, other goods and services, large research infrastructure) (table 3.4.b) Summary of consortium partners own contribution Summary and cost of the additional investments
Formulario B: Ejemplo Research & Innovation/Innovation Action
19
5. Ethics Issues
Formulario B: Ejemplo Research & Innovation/Innovation Action
• Template for Ethics Issues Table http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/hi/ethics/ethics-eit_en.pdf
• Ethics Self-assessment http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/hi/ethics/h2020_hi_ethics-self-assess_en.pdf
• Participan Portal H2020 –OnLine Manual http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/ethics_en.htm
4. Members of the consortium 4.1. Participants (applicants) 4.2. Third parties involved in the project (including use of third party resources)
20
El evaluador!!
http://ec.europa.eu/research/participants/portal/desktop/en/exp
erts/index.html
“Si no puedes con tu enemigo, únete a él”
21
http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/pse/h2020-evaluation-faq_en.pdf
La Guía de los evaluadores de H2020
22
Guidance for evaluators of H2020 proposals
How should XXXXX be adressed and evaluated in the proposals?
• Innovation • Social Sciences and Humanities (SSH) - list of SSH-
relevant topics. • Responsible Research and Innovation (Open
Access) / • Public Engagement • Gender dimmension • Transdisciplinarity • Intenational Cooperation • Communication activities
La Guía de los evaluadores de H2020
http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/pse/h2020-evaluation-faq_en.pdf
23
"Our focus is on supporting the best research ideas that provide major
business opportunities"
Commissioner Geoghegan-Quinn
30 Nov 2011
"from research and innovation to market
deployment."
EU Council Conclusions
24/25 October 2013
“R&I are crucial to boosting the growth and job creation that EU so
desperately needs"
Commissioner Carlos Moedas
16 Feb 2015
“ensuring effective use
of H2020 project
results”
H2020 y la INNOVACIÓN
El mensaje “de la investigación al
mercado” se ha materializado en la
forma de evaluar
24
La INNOVACIÓN en los criterios de evaluación
'Excellence' criterion (excerpt)
• Extent that the proposed work is beyond the state of the art and demonstrates innovation potential (e.g. ground-breaking objectives, novel concepts and approaches, new products, services or business and organizational models)
'Impact' criterion (excerpt)
• … enhance innovation capacity, create new market opportunities, strengthen competitiveness and growth of companies, address … the environment, or bring other important benefits for society;
'Quality & efficiency of the implementation' (excerpt)
• Appropriateness of the management structures and procedures, including risk and innovation management.
Note: For 'Innovation' actions the score for 'impact' will be weighted by a factor of 1.5
25
CLEAR EMPHASIS ON EVERYWHERE
IN YOUR
PROPOSAL
26
Ambición. Cuantificar!! •Impactos EUROPA 2020,
Innovation Union, políticas industriales, medioambientales, Estrategia de Bioeconomía, Economía Circular, …
•Mercados
•Volumen de negocio
•Creación de empleo
Es necesario CONVENCER
27
Plan de Negocio en H2020 en la práctica
Fuente: MobillsLabs - Business Model Canvas
28
Plan de Negocio en H2020 en la práctica
31
Responsible Research and Innovation Europe´s ability to respond to societal challenges
European Commission
RRI is now a legal text of H2020 from the European Parliament, Preamble 22 (our emphasis): (22) With the aim of deepening the relationship between science and society and reinforcing public confidence in science, Horizon 2020 should (…) by developing responsible research and innovation agendas that meet citizens´and civil society´s concerns and expectations…
April 2012
El concepto RRI- Investigación e Innovación Responsable
32
RRI – Responsible Research Innovation. 6 keys
1. Public engagement 2. Gender equality
4. Open access
5. Ethics
6. Gorvernance
Sustainability
Social justice
Inclusion
2. Science Education
Other areas:
El concepto RRI- Investigación e Innovación Responsable
33
• Es obligatorio para los beneficiarios de H2020 (todas las áreas*) depositar en abierto todas las publicaciones científicas que se elaboren en el marco de la investigación financiada por el programa.
• La CE ha lanzado un piloto que hace obligatorio el
depósito abierto de los datos de investigación producidos en el marco de los proyectos. Para varias areas de H2020 (Ciencia Excelente – FET e Infraestructuras, LEIT-ICT, Retos sociales 3,5,6) y SSH)
*Incluido el RS2 de Bioeconomía
El mandato de Acceso Abierto en H2020
34
¿Qué es el acceso abierto?
Acceso abierto: acceso on line sin trabas ni coste para el usuario final: –a publicaciones científicas revisadas por pares. –a datos de investigación.
Sin embargo, el acceso abierto:
–no implica la exigencia de publicar: los investigadores tienen libertad para decidir si publicar o no. –no interfiere con la decisión de explotar comercialmente los resultados de investigación (ej. patentar): la obligación de depositar en acceso abierto se produce una vez se ha tomado la decisión de publicar. –las publicaciones no son de menor calidad: están sometidas al mismo proceso de revisión por pares que las publicaciones de acceso comercial.
El mandato de Acceso Abierto en H2020
35
En los formularios de las propuestas y en el Grant Agreement. 2.2 Measures to maximise impact a) Dissemination and exploitation of results
El mandato de Acceso Abierto en H2020
36
El mandato de Acceso Abierto en H2020. Enlaces de interés
Portal del Participante/ Reference Documents Guidelines on Open Access to Scientific Publications and Research Data. Guidelines on Data Management https://www.openaire.eu/factsheets/support/h2020 Acceso abierto datos de investigación Obligaciones Re3data (www.re3data.org ); Zenodo (www.zenodo.org ) Plan de Gestión de Datos: http://www.consorciomadrono.es/pagoda A la hora de escribir una propuesta, tener en cuenta: Winning Horizon2020 with Open Science?
El mandato de Acceso Abierto en H2020
37
Objetivos de Igualdad de Género en H2020 • Asegurar el equilibrio de género en la toma de decisiones. • Promover el equilibrio de género en los equipos de investigación. • Integrar el análisis de género en el contenido de la investigación y la
innovación.
“Sex” is a biological quality
“Gender“ is a socio-cultural process
Gender Equality in Horizon 2020 http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/hi/gender/h2020-hi-guide-gender_en.pdf Fact sheet: Gender Equality in Horizon 2020 https://ec.europa.eu/programmes/horizon2020/sites/horizon2020/files/FactSheet_Gender_091213_final.pdf
El Género en los proyectos de H2020.
38
2.2. Measures to maximise impact b) Communication Activities
• Las actividades de comunicación se desarrollarán en un
WP específico o como parte de otro. • Estarán planificadas desde la concepción del proyecto y
se desasrrollarán a lo largo del mismo, con objetivos claros, estratégicamente planificados, dirigidos a distintas audiencias y eligiendo los mensajes pertinentes.
• Utilizar distintos medios (locales, regionales, nacionales, UE); one-way exchange (web, prensa, folletos), o two-ways exchange (feria, visita a colegio, debate por internet, …)
• La comunicación será acorde a la escala de la acción.
http://ec.europa.eu/research/participants/data/ref/h2020/other/gm/h2020-guide-comm_en.pdf
Beneficiaries have the obligation to
“promote the action & its results”
La Comunicación en H2020
http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/main/h2020-wp1415-comm-
diss_v1.0_en.pdf
39
Estandarización
Fuente: IPR
Helpdesk
http://www.cencenelec.eu/research/tools/Horizon2020/Pages/default.aspx
40
Estandarización
Technical bodies: http://standards.cen.eu • Biotechnology ISO TC 276 • Waste
CEN-TC 400 sludge, biowaste and soil, CEN - TC183 waste management
• Biobased products JTI-BBI: CEN-TC 19 Gaseous liquid fuels CEN-TC249 Plastics CEN-TC276 Surface ative agents CEN-TC411 Biobased products
• Biofuels • Food
41
Documentos útiles
BBI JU-FAQs Self-evaluation form RIA, IA & CSA
42
H2020 Online Manual
43
Recomendaciones finales
• Releer el topic las veces que sea necesario. • Seguir la Guia del solicitante para que el evaluador encuentre fácilmente la
información que está buscando. • Tener en cuenta la diferencias de una propuesta BBI vs. H2020 e incidir en
cumplimentar adecuadamente las diferencias (aspectos financieros – industry own contribution/Additional investments.
• Ponerse en el lugar del evaluador. Tener en cuenta los criterios y subcriterios de evaluación.
• La innovación está de moda y se evalúa, fundamentalmente en el impacto (mercado, oportunidad de negocio, …)
• Cuantificar • Coherencia en la escritura. • Menos es mas. Pónselo fácil al evaluador apoyandose en gráficos, tablas,
dibujos. • Consulta los documentos de apoyo en el H2020 Online Manual. (IPR, gender,
RRI, Open Access) • Utilizar toda la ayuda disponible (NCPs, …)
44
Documentos y páginas web de interés
Documentos de interés:
BBI JU Work Plan 2016
BBI JU Calls - Guide for applicants (RIA-DEMO-CSA)
Frequently Asked Questions (updated 22/04/2016) BBI JU Scientific Innovation and Research Agenda (SIRA) Horizon 2020 Rules for participation BBI JU Derogation to H2020 Rules for Participation BBI JU Regulation of establishment
Standard evaluation form (CSA)
Standard evaluation form (RIA)
Standard evaluation form (FLAG and DEMO)
BBI JU Model Grant Agreement – Multi-Beneficiary
H2020 Annotated Grant Agreement
Páginas web de interés:
Bio-based Industries Public-Private Partnership
http://bbi-europe.eu
Bio-based Industries Consortium:
http://biconsortium.eu
BBI Partnering Platform
http://bbi-europe.eu/participate/bbi-partnering-platform
Ayudas a la Preparación de Propuestas Comunitarias (APC)
http://www.cdti.es/index.asp?MP=7&MS=572&MN=3&TR=C&IDR=600
Listas de distribución del portal español de H2020
http://www.eshorizonte2020.es/suscripcion
Acceso a la convocatoria H2020-BBI-2016 a través del: Participant Portal
H2020 & CDTI SERVICIO DE VALOR AÑADIDO PARA
GRUPOS DE INVESTIGACIÓN, EMPRESAS, ADMINISTRACIONES
Y USUARIOS Guía del participante H2020
http://www.guiah2020.es/index.php
46
Thanks for your attention!
Any questions?
Marta Conde National Contact Point for SC2 Bioecnonomy & LEIT “Biotech”
José Manuel González Spanish Delegate to SC2 Bioeconomy
CDTI Ministry of Economy and Competitiveness
International Programmes Directorate European Programmes Division
+34 91 581 55 62.- [email protected]; [email protected]
